| Glenn W Errington, MD | |
|
2600 E 7th St, Unit A, Charlotte, NC 28204-4375 | |
| (704) 372-7900 | |
| (704) 376-2216 |
| Full Name | Glenn W Errington |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 2600 E 7th St, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942236013 | NPI | - | NPPES |
| 8930769 | Medicaid | NC | |
| 137694 | Medicaid | SC | |
| 01284 | Other | NC | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 29565 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Glenn W Errington, MD Po Box 63376, Charlotte, NC 28263-3376 Ph: (704) 372-7900 | Glenn W Errington, MD 2600 E 7th St, Unit A, Charlotte, NC 28204-4375 Ph: (704) 372-7900 |
News Archive
Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced financial results for the second quarter ended June 30, 2010.
Although hip fractures in older patients are known to be a major cause of long term disability and increased risk of death, less is known about the relationship between surgical delay after hip fracture and mortality risk.
The coronavirus (COVID-19) outbreak has now spread to 87 countries, including the United Kingdom, which has now recorded its first UK coronavirus death in Berkshire. Now, government officials are suggesting the closure of parliament to prevent the spread of the virus.
Ferring Pharmaceuticals Inc. today announced publication of one of its pivotal Phase 3 trials of LYSTEDA (tranexamic acid) tablets for cyclic heavy menstrual bleeding in the October issue of the peer-reviewed journal, Obstetrics & Gynecology. The six-month clinical trial demonstrated that LYSTEDA significantly reduced menstrual blood loss from baseline, and improved health-related quality-of-life parameters in women with cyclic HMB while maintaining safety and tolerability.
› Verified 8 days ago
Dr. Cheryl Lynn Walker-mcgill, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 1404 Beatties Ford Rd, Suite 200, Charlotte, NC 28216 Phone: 704-344-2100 | |
John T Klimas, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 2600 E 7th St, Unit A, Charlotte, NC 28204 Phone: 704-372-7900 Fax: 704-376-2216 | |
Sanjay J Khiani, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 10370 Park Rd, Suite 202, Charlotte, NC 28210 Phone: 704-817-2022 Fax: 704-817-2024 | |
Ekta B. Shah, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 10650 Park Rd, Charlotte, NC 28210 Phone: 704-667-3960 | |
Shannon N Chadha, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2600 E 7th St, Unit A, Charlotte, NC 28204 Phone: 704-372-7900 Fax: 704-376-2216 | |
Richard S Roberts, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2600 E 7th St, Unit A, Charlotte, NC 28204 Phone: 704-372-7900 Fax: 704-376-2216 | |
Dr. John Gray Norris, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2600 E 7th St, Unit A, Charlotte, NC 28204 Phone: 704-372-7900 Fax: 704-376-2216 |